Controversy exists over the nature of the abnormality in cardiac sympathetic nerves in heart failure. In the cardiomyopathy of the Syrian hamster, reduction in tissue stores and increased turnover of norepinephrine is clearly associated with excessive sympathetic stimulation but in animal models and humans with heart failure secondary to mechanical overload there is evidence for depression of neuronal uptake. Because norepinephrine is both released and taken up by sympathetic fibers it is impossible to assess norepinephrine kinetics in an intact heart without separating these two functions. A technique for doing so has recently been developed in normal dogs and we therefore acquired similar data in humans with heart failure secondary to chronic pressure and volume overload. The technique involves the combination of transient norepinephrine tracer coronary sinus outflow in relation to intravascular and interstitial references after simultaneous injection into the left coronary artery and the measurement of endogenous norepinephrine concentrations in artery and coronary sinus. We found a marked reduction in cardiac norepinephrine release and uptake in a group of patients with clinical left ventricular failure secondary to mechanical overload, relative to a group of patients with no failure. Norepinephrine balance and overflow across the heart were not significantly different. We conclude that there is hypofunction of the cardiac sympathetic nerves in heart failure secondary to mechanical overload and that traditional methods are inadequate in assessing cardiac norepinephrine kinetics when there are simultaneous changes in neuronal uptake and release.
Introduction
Chronic myocardial failure is associated with abnormalities in the sympathetic nervous system. Tissue levels of norepinephrine are reduced (1) (2) (3) (4) in cardiac muscle and plasma levels are increased (5, 6) . From studies on the cardiomyopathic Syrian hamster it has been surmised that cardiac tissue depletion in humans with chronic heart failure due to mechanical overload is due to increased sympathetic stimulation (7, 8) . Indeed, Swedberg et al. (9, 10) sinus norepinephrine balance in human heart failure of various etiologies.
Since norepinephrine is both released and taken up by sympathetic nerve fibers it is impossible to assess the true neuronal release from simple measurement ofarterial and coronary sinus norepinephrine concentrations. Thus, it is possible that both release and uptake could be reduced with little or no change in arterio-venous extraction. This hypothesis became more tenable when we showed in humans with heart failure secondary to chronic overload that sympathetic neuronal uptake of epinephrine, which is normally not released from peripheral sympathetic fibers, is reduced in the heart but not in the lower limb (1 1). Norepinephrine overflow was normal or increased. This observation confirmed several previous suggestions that in chronic heart failure secondary to mechanical overload there is a defect in the neuronal uptake and release that was specific to the heart and not part of a generalized exhaustion of the sympathetic system (2, 3, 12) .
Clearly what was needed was a nondestructive technique for measuring both neuronal uptake and release of norepinephrine in the intact, in situ human heart. Fortunately such an approach had been developed in the normal dog in our institution (13) . Since the technique involves only analysis of transient tracer norepinephrine uptake in concert with endogenous arterial and coronary sinus norepinephrine concentrations, it is easily adapted to humans in the environment of the cardiac catheterization laboratory.
Methods

Patient selection
Patients referred to the cardiac catheterization laboratory of the Montreal General Hospital for routine diagnostic studies were selected and divided into two groups by the following criteria: group A had valve disease, predominantly mitral stenosis with no evidence of left ventricular hypertrophy on the electrocardiogram and no previous history ofpulmonary edema; group B had valve disease with any combination ofaortic stenosis, aortic insufficiency, or mitral insufficiency, electrocardiographic left ventricular hypertrophy, and a history of pulmonary edema confirmed by chest roentgenography. All patients were over the age of 40 yr and therefore required routine coronary angiography to rule out significant coronary artery disease. None 
Multiple indicator dilution
A run consisted of injecting 0.75 ml of the injection mixture (see below) into the left coronary ostium while simultaneously collecting samples from the coronary sinus into heparinized tubes on a moving rack at a rate of -0.75 s per sample. Arterial pressure, heart rate, and electrocardiogram were monitored continuously. No change occurred in any of these parameters during the run in any patient.
Injection mixture
The injection mixture was composed of autologous blood adjusted to the hematocrit of each patient. It contained the following radioactive tracers: '25I-albumin (Charles E. Frosst, Pointe Claire, Quebec, Canada), a reference substance that does not leave the coronary circulation within a single passage; [U-'4C]sucrose (New England Nuclear, Boston, MA), a diffusible substance that leaves the circulation to enter the extracellular space during its passage through the coronary capillaries; and N- [1,7- 3H]norepinephrine (sp act, 30.0 Ci/mol, New England Nuclear).
Sample analysis
A sample of 0.1 ml from each heparinized tube collected during the run was diluted with 1.5 ml of saline, pipetted into a counting tube, and assayed for radioactivity in a gamma ray spectrometer set for the photopeak characteristic of 125I. The proteins were then precipitated with 0.2 mol of trichloroacetic acid, and 0.2 ml of the supernatant fluid was pipetted into a scintillation cocktail and assayed for`4C and 3H activity in a liquid-scintillation counter. Samples from the injection mixture, diluted with blood, and crossover standards were treated identically. To compare the relative magnitudes of the three tracers at the outflow, the activity in each sample was normalized by dividing the activity by the respective concentration in the injection mixture. The resulting value is the outflow fraction of the total injected per milliliter of venous blood.
For determination of catecholamine levels, 3 ml of blood was transferred to ice-cold tubes that contained glutathione and EGTA, as described by Peuler and Johnson (14) . Norepinephrine and epinephrine levels determined in duplicate in 50 ul of plasma by the radioenzymatic method outlined by these authors with only minor modifications (Cat-a-Kit, Upjohn Co., Kalamazoo, MI).
Qualitative description ofdata
Normalized coronary sinus outflow curves obtained in patients from the two groups are shown in Fig. 1 . Initial insight into this data's meaning is aided by consideration of the events occurring in a single capillary as the bolus oftracers travels along it. Since labeled albumin does not leave the capillaries in a single passage to any significant extent, the time of its outflow is determined solely by the transit time of the capillary. In the whole organ there will of course be a distribution of pathways connecting inlet and outlet. Labeled sucrose occupies the same plasma space as albumin but also permeates the capillary barrier via aqueous channels and enters the interstitial space. It does not cross any cell membranes and is therefore a reference for the interstitial space. In the early samples the sucrose curve is reduced in relation to the albumin curve because of diffusion from the capillary, but later, as labeled sucrose returns from the interstitial space, its concentration is higher than that of albumin, which has already left the capillary. Labeled norepinephrine is handled in a similar fashion at the capillary surface but its removal and concentration by the sympathetic fibers in the interstitial space, which run parallel to the capillaries, reduces the amount returning from the interstitial space. Since Chidsey et al. (15) have shown that 3 min after injecting labeled norepinephrine into the coronary artery of the canine heart, the metabolites of norepinephrine constitute only a barely perceptible proportion of the total radioactivity measurable in the coronary sinus, we have as- (Fig. 1, left) , there is a such a large extraction of labeled norepinephrine that its outflow concentration never rises above the labeled albumin curve. This pattern is identical to that found in the normal dog. In a patient with clinical heart failure secondary to chronic aortic and mitral valve disease, left ventricular hypertrophy and dilated heart (Fig. 1, right) , there is a marked reduction in labeled norepinephrine sequestration and the pattern of outflow is close to that of sucrose. This pattern is reminiscent ofthat obtained after inhibition of neuronal uptake by desmethylimipramine in the dog (13) . While inspection of the data suggests that cardiac neuronal uptake is decreased in patients with heart failure, it is only possible to quantitate the reduction and calculate the norepinephrine release by means of a mathematical model ofthe bloodtissue exchange process.
Mathematical modeling
Transient tracer outflow. The assumptions underlying and the description of the model of blood-tissue exchange of sequestered substances in the coronary circulation as well as the methods for its calculation have been described extensively in previous publications (13, (16) (17) (18) (19) , but the main points are outlined here so that the reported parameters can be related to their position in the equations of the model. First, a single capillary model is derived and then this is inserted into a whole-organ model with variable capillary transit times. Fig. 2 shows diagrammatically the single capillary model for irreversible sequestration of norepinephrine by sympathetic neurons in the interstitial space. The assumptions corresponding to this are that (a) dispersionless plug flow occurs in the capillary; (b) longitudinal diffusion can be neglected because the axial dimension is very large with respect to the radial dimension; (c) radial diffusional equilibration is so rapid that no concentration gradients exist in this direction within any ofthe spaces; (d) substrate sequestration takes place with first-order kinetics. In the modeling and in the illustration the following symbols are used: A and B are the volumes per unit length for capillary and interstitial spaces, respectively; W is the velocity of blood flow; u(x, t) and v(x, t) are, respectively, tracer concentrations at some point, x, along the length of the unit and at time, t; k, and k2 are permeability-surface products per unit interstitial space for flux out ofand into the capillary, respectively; k3 is the first-order unidirectional rate constant per unit interstitial space for irreversible sequestration by the neuron; and R is the rate of release of unlabeled norepinephrine from the neuronal pool.
Consideration of the events occuring at each element in space and time leads to two partial differential equations that must be solved simultaneously. The first for the conservation of matter is:
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The second, the rate equation for accumulation of tracer in the interstitial space, is: where 6 symbolizes the Dirac delta or impulse function. The first term is the "throughput" or "nonexchanging" component and represents an initial impulse arriving at the outflow concurrently with the vascular reference but reduced in magnitude by the factor exp(-k1'YT). Note that klyTc can also be written as PS/FC, where P is the permeability of the capillary and S is its surface area. The second term, the "returning component," describes the outflow of material that permeated the wall of the capillary and then returns to it after the throughput has exited. These two components correspond roughly to the peak and downslope of the whole-organ outflow. The expression for the returning component is particularly complicated and the interested reader is asked to consult the above references.
The construction of the whole-organ model requires three more as- Eq.7
Note that in general 'y is not an independent parameter but in the wholeorgan transform is always combined with either TC,,, or b. Also in practice it is not possible to obtain absolute capillary transit times, and the parameters Tcmin and b are replaced by a' = k'YTcmin, and b' = klyb, respectively.
Because real data are truncated, usually at the onset ofrecirculation, the transform of these data can be obtained only through extrapolation. Empirically outflow curves are known to always decrease monoexponentially in their final phase. To fit the data in the transform or frequency domain one last assumption is needed: (h) all dilution curves can be extrapolated monoexponentially.
In the case of completely recovered permeating tracer such as sucrose, the downslope can be extrapolated so that its recovery matches that for the vascular reference, albumin. For norepinephrine whose recovery is necessarily less than complete, it is necessary to define a terminal slope by running a regression line through the last few data points. The extrapolated curves can then be fitted sequentially in the frequency domain. This is done by iterative adjustment of the model parameters until the predicted outflow of the permeating tracer matches the data as closely as possible given the form of the vascular reference in the same experiment.
A set of outflow curves such as those displayed in Fig. 1 yields six unique, optimized parameters and one model-independent parameter, which characterize the state ofcapillary exchange in the 20-30 s in which the tracers are passing through the coronary microcirculation. For sucrose, the optimized parameters are: k(=k1=k2), the capillary permeabilitysurface product per unit interstitial space; and a' and b', which describe the heterogeneity of capillary transit times. For norepinephrine the parameters are: k,(=k,=k2), the capillary permeability-surface product per unit interstitial space for norepinephrine; k,(=k3), the rate constant for unidirectional sequestration by the sympathetic neurons; and 'y, the ratio of the accessible interstitial space for norepinephrine relative to sucrose. The model-independent parameter is phi, the plasma flow per unit interstitial space. It is calculated as the inverse of the difference in mean transit times between albumin and sucrose.
Steady-state uptake and release. These parameters can be used in combination with the endogenous catecholamine concentration to derive estimates of steady-state rates of neuronal uptake and release. It can be shown (13) (C,,, -C,,,) /QC ,. The norepinephrine balance, phi (C. -Cn)/Cn, requires only the measurement of coronary flow but completely ignores the existence of simultaneous uptake and release. The norepinephrine overflow = phi{ C,, -Cm (1 -E)}, where E is the steady-state extraction of labeled norepinephrine, and has been recommended as a means of correcting for simultaneous norepinephrine uptake (20) . The steady-state extraction can be estimated from our data by using the ratio of the difference between the areas subtended by the albumin and norepinephrine curves to the area under the albumin curve. However, this calculation still ignores the influence of the capillary barrier on the exchange process. Even if all norepinephrine were completely removed from the interstitial space by the neurons, 30-40% of the arterial input would appear in the coronary sinus (17) . Thus net overflow is relatively insensitive to alterations in neuronal release and uptake.
Differences between means for each parameter in the two groups were determined by the unpaired t test. The null hypothesis was rejected at the level of 0.05. Table I shows clinical data, endogenous norepinephrine concentrations, coronary sinus oxygen saturation, phi (plasma flow per unit interstitial space), and norepinephrine balance and labeled norepinephrine extraction for each patient in the two groups. The only difference was a significant reduction in the labeled norepinephrine extraction in the heart failure group (33% vs. 73% in group A). As in our previous study (1 1) , the aortocoronary sinus epinephrine extraction was negligible in the failure group. findings, there is also no generally accepted unequivocal index
Results
Effect of hypertrophy and failure on interstitial space size. of contractility, particularly in the presence of regurgitant valve Because the total amount oftracer entering the coronary ostium lesions. We therefore assumed that those patients with electrois not known with certainty, the multiple indicator dilution cardiographic left ventricular hypertrophy and at least one eptechnique as employed in this study allows estimation of the isode of radiologic pulmonary edema have reduced left ventrictransport parameter relative to the interstitial space. Ifthere were ular contractility secondary to chronic mechanical overload. major changes in interstitial space size in hypertrophy, this would Even with this imprecise definition every one of the patients in be reflected in an artifactual reduction in the rate constant for group B had a rate constant for neuronal uptake of norepinorepinephrine sequestration, kn. Fuster et al. (21) found only nephrine far below the range in group A. Interestingly, the means a nonsignificant increase in interstitial space size (35.7%) in the of the model parameters for group A are with minor variations autopsied left ventricle of patients with mitral regurgitation and identical to those for the normal dog (13) . moderate heart failure. There was a 50% increase in interstitial also occur in patients with heart failure secondary to mechanical overload but has not been reported as yet. Cardiac norepinephrine release and circulating catecholamines. Fig. 6 shows that as well as a significant difference in the mean norepinephrine release in the two groups, there is a more striking difference when release is related to coronary sinus norepinephrine concentration, a crude index of degree of sympathetic stimulation. Evidence for depression of the uptake function of the nerves in animal models (2, 3) and in human autopsy material (12) has been obtained previously. It may be deduced that if there were no substantial net positive balance of endogenous norepinephrine across the heart, neuronal release would have to decrease in concert with the decreased uptake, but no direct evidence for this had been obtained previously. Indeed, we have shown that it is only with detailed analysis of the transient kinetics of blood-tissue exchange that one can show such a phenomenon. Even the use of steady-state labeled norepinephrine extraction is not sensitive enough to detect the marked inhibition of release.
Congestive heart failure is known to be associated with increased circulating catecholamines (5, 25) . This study raises the obvious question of the origin of these increased levels if the heart is releasing much less than usual for a given concentration in the coronary sinus. In the absence of any evidence that stimulation of cardiac nerves can be specifically inhibited during massive stimulation of the peripheral sympathetic nervous system such as occurs with heart failure, we must conclude either that in heart failure all of the circulating catecholamines are coming from the adrenal medulla, or that there is a localized defect in the cardiac nerves. Because the adrenal medulla secretes mostly epinephrine and because circulating epinephrine-to-norepinephrine ratio is not increased in heart failure (25) , the increased levels must be due to stimulation of extracardiac peripheral nerves. The concept of localized cardiac sympathetic dysfunction in heart failure is supported by a previous study from this institution that showed normal epinephrine extraction across the lower limb in spite of absent epinephrine extraction across the heart in patients with heart failure ( 11) and by studies in animal models ofheart failure in which tissue levels and uptake were decreased in the heart but not in the kidney (2, 3) .
Interstitial norepinephrine concentration. Bristow's group (32) has observed a reduction in beta-adrenergic receptor density in failing human hearts removed during heart transplantation. Since they also observed a localized reduction of receptors in the right ventricle of patients with right heart failure secondary to pulmonary hypertension (33), they proposed that a localized defect in uptake would cause increased interstitial norepinephrine concentration and consequent down regulation of beta-adrenergic receptors. Of course the alternative explanation is that failing muscle cells do not make the normal complement of receptors. In the present study the patients with heart failure secondary to valve disease did not have significantly elevated calculated average interstitial norepinephrine concentration but neither did they have elevated circulating levels. Note that interstitial concentration is a complicated function of cardiac neuronal release and uptake and circulating levels. This problem can only be answered by combining the analysis of norepinephrine kinetics as reported here with measurement of beta receptor density in either operative or transvenous biopsies.
Conclusions and significance. We have shown that patients with relatively mild left ventricular failure (no increase in circulating norepinephrine concentration) have defective cardiac sympathetic innervation. This defect must be confined to the heart because circulating levels are normal. The underlying cause ofthis association between failing cardiac myocytes and defective nerve function must remain speculative at present. There are two possibilities: failing myocytes could release a toxic substance that injures the adjacent axons; or both myocytes and axons could be exposed to the same detrimental external factor (hypoxia?). This finding could potentially form the basis of a test for early heart failure if it could be shown that the nerves are affected early in the disease and a suitable imaging agent could be found that is taken up by the same axonal transport system as norepinephrine.
